Retatrutide has emerged as a new treatment in the fight against obesity. This novel drug, belonging to a dual GLP-1 and GIP receptor agonist, shows promising results in research studies. By activating these receptors, Retatrutide reduces hunger pangs, {promotesenergy expenditure, and ultimately results in significant weight loss. While research is